Published in Curr Opin Nephrol Hypertens on May 01, 2010
Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans. PLoS Genet (2011) 1.57
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans. Nephrol Dial Transplant (2011) 1.18
Renal disease in HIV-infected individuals. Curr Opin HIV AIDS (2011) 1.15
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun (2011) 1.07
Hypertension, glomerular hypertrophy and nephrosclerosis: the effect of race. Nephrol Dial Transplant (2013) 1.01
The new era of APOL1-associated glomerulosclerosis. Nephrol Dial Transplant (2012) 0.93
Increased circulating inflammatory endothelial cells in blacks with essential hypertension. Hypertension (2013) 0.87
Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes. Semin Dial (2010) 0.85
Hypertension and chronic kidney disease: controversies in pathogenesis and treatment. Minerva Urol Nefrol (2013) 0.81
Risk factors: Race, renal disease and albuminuria. Nat Rev Nephrol (2011) 0.75
Cisplatin-Induced Nephrotoxicity and HIV Associated Nephropathy: Mimickers of Myeloma-Like Cast Nephropathy. Case Rep Nephrol (2017) 0.75
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med (1994) 11.65
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet (2000) 7.39
Cell biology of the glomerular podocyte. Physiol Rev (2003) 6.85
A millennial myosin census. Mol Biol Cell (2001) 6.13
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature (1990) 4.64
Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol (2007) 4.31
Myosins: a diverse superfamily. Biochim Biophys Acta (2000) 4.30
Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk. Nat Cell Biol (2007) 4.26
Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA (1992) 3.86
CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science (2003) 3.61
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int (2009) 3.58
Myosin 2 is a key Rho kinase target necessary for the local concentration of E-cadherin at cell-cell contacts. Mol Biol Cell (2005) 3.43
Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol (2006) 3.31
The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01
Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. Nephrol Dial Transplant (2009) 2.88
The progression of renal disease. N Engl J Med (1988) 2.70
Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis (2004) 2.51
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol (2007) 2.26
Renal insufficiency in treated essential hypertension. N Engl J Med (1989) 2.17
Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney Int (1997) 2.11
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) (2003) 2.05
Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis (1988) 1.99
Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol (2003) 1.97
Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis (1995) 1.96
Cumulative risk for developing end-stage renal disease in the US population. J Am Soc Nephrol (2002) 1.93
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol (2009) 1.80
Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. J Am Soc Nephrol (2002) 1.79
Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int (1976) 1.77
Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int (2002) 1.69
Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol (2008) 1.68
Hypertension-associated kidney disease: perhaps no more. J Am Soc Nephrol (2008) 1.68
Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up. Hypertension (1989) 1.64
HIV-associated nephropathy in African Americans. Kidney Int Suppl (2003) 1.56
Is there an epidemic of HIV Infection in the US ESRD program? J Am Soc Nephrol (2004) 1.56
Chromogranin A regulates renal function by triggering Weibel-Palade body exocytosis. J Am Soc Nephrol (2009) 1.55
Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol (1998) 1.54
Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int (2009) 1.48
Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol (2005) 1.38
Inaccuracy of clinical phenotyping parameters for hypertensive nephrosclerosis. Nephrol Dial Transplant (2000) 1.33
MYH9-related platelet disorders. Semin Thromb Hemost (2009) 1.30
Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease. Int J Mol Med (2006) 1.26
Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis (1994) 1.25
Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome. Pediatr Nephrol (2003) 1.25
Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells. Invest Ophthalmol Vis Sci (2007) 1.22
Nonimmunologic mechanisms of glomerular injury. Lab Invest (1988) 1.22
Genotype-phenotype correlation in MYH9-related thrombocytopenia. Br J Haematol (2005) 1.20
Glomerular epithelial-mesenchymal transdifferentiation in pauci-immune crescentic glomerulonephritis. Nephrol Dial Transplant (2003) 1.18
Outcomes associated with race in males with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.16
A genome-wide affected sibpair linkage analysis of hypertension: the HyperGEN network. Am J Hypertens (2003) 1.12
Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report. Am J Kidney Dis (2010) 1.04
Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Am J Epidemiol (1995) 1.01
Renal biopsy findings in presumed hypertensive nephrosclerosis. Am J Nephrol (1994) 0.99
TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest (1994) 0.99
Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int Suppl (2005) 0.97
Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury. J Am Soc Nephrol (2009) 0.97
Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci (2008) 0.95
Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure. Adv Ren Replace Ther (2004) 0.88
Glomerular crescents predominantly express cadherin-catenin complex in pauci-immune-type crescentic glomerulonephritis. Histopathology (2003) 0.87
End-stage renal disease in two pediatric patients with Fechtner syndrome. Pediatr Nephrol (1999) 0.84
Does non-malignant hypertension cause renal insufficiency? Evidence-based perspective. Curr Opin Nephrol Hypertens (2002) 0.82
Effect of community characteristics on familial clustering of end-stage renal disease. Am J Nephrol (2009) 0.82
Antihypertensive drug treatment. Potential, expected, and observed effects on stroke and on coronary heart disease. Hypertension (1989) 0.79
Racial differences in the incidence of end-stage renal disease. Ethn Health (1996) 0.79
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (2010) 16.00
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans. Kidney Int (2012) 3.46
Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. Am J Gastroenterol (2008) 3.16
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy. Kidney Int (2013) 3.09
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet (2011) 2.54
Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15. Hum Mol Genet (2010) 2.51
Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes (2008) 2.41
Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans. Nephrol Dial Transplant (2011) 2.26
A genome scan for diabetic nephropathy in African Americans. Kidney Int (2004) 2.00
A genome-wide association study for diabetic nephropathy genes in African Americans. Kidney Int (2010) 1.98
Pericardial and visceral adipose tissues measured volumetrically with computed tomography are highly associated in type 2 diabetic families. Invest Radiol (2005) 1.98
Familial clustering of chronic kidney disease. Semin Dial (2007) 1.95
Heritability of body composition measured by DXA in the diabetes heart study. Obes Res (2005) 1.94
The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. J Diabetes Complications (2005) 1.87
Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes (2007) 1.86
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol (2003) 1.85
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes (2007) 1.79
Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke (2002) 1.78
An update on pruritus associated with CKD. Am J Kidney Dis (2007) 1.75
The spectrum of MYH9-associated nephropathy. Clin J Am Soc Nephrol (2010) 1.72
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Genetic factors in end-stage renal disease. Kidney Int Suppl (2005) 1.71
Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud (2010) 1.69
Chromogranin A polymorphisms are associated with hypertensive renal disease. J Am Soc Nephrol (2008) 1.68
Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet (2012) 1.68
Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes (2007) 1.61
Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study. Nephrol Dial Transplant (2006) 1.59
Informed conditioning on clinical covariates increases power in case-control association studies. PLoS Genet (2012) 1.57
Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes (2008) 1.53
Race-specific relationships between coronary and carotid artery calcification and carotid intimal medial thickness. Stroke (2004) 1.53
Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.52
Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. Am J Nephrol (2011) 1.52
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49
Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis (2004) 1.47
Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics. J Am Soc Hypertens (2013) 1.47
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet (2010) 1.43
Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev Diabet Stud (2012) 1.42
Coronary calcium score and prediction of all-cause mortality in diabetes: the diabetes heart study. Diabetes Care (2011) 1.41
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet (2012) 1.41
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis (2011) 1.41
Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes (2006) 1.39
A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes. PLoS Genet (2010) 1.38
Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease. Hum Genet (2008) 1.36
The impact of FADS genetic variants on ω6 polyunsaturated fatty acid metabolism in African Americans. BMC Genet (2011) 1.35
Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes (2010) 1.30
Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci (2008) 1.29
A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q. Diabetes (2004) 1.26
Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes (2008) 1.22
Admixture mapping of coronary artery calcified plaque in African Americans with type 2 diabetes mellitus. Circ Cardiovasc Genet (2012) 1.22
Gene-gene interactions in APOL1-associated nephropathy. Nephrol Dial Transplant (2013) 1.21
Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome. Br J Nutr (2011) 1.20
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum (2011) 1.19
Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy. Am J Kidney Dis (2011) 1.19
Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int (2005) 1.18
Calcified atherosclerotic plaque and bone mineral density in type 2 diabetes: the diabetes heart study. Bone (2007) 1.18
Genetic risk assessment of type 2 diabetes-associated polymorphisms in African Americans. Diabetes Care (2012) 1.17
Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study. Diabetes Care (2009) 1.15
Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production. PLoS Genet (2013) 1.14
Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum Mol Genet (2012) 1.14
A comparison of risk factors for calcified atherosclerotic plaque in the coronary, carotid, and abdominal aortic arteries: the diabetes heart study. Am J Epidemiol (2007) 1.13
Transferability and fine mapping of type 2 diabetes loci in African Americans: the Candidate Gene Association Resource Plus Study. Diabetes (2012) 1.12
Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study. Diabetes Care (2012) 1.12
The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans. Hum Genet (2009) 1.11
Basic performance of an enzymatic method for glycated albumin and reference range determination. J Diabetes Sci Technol (2011) 1.08
Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis. Clin J Am Soc Nephrol (2011) 1.08
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study. Circulation (2013) 1.07
Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol (2011) 1.07
Sickle cell trait and development of microvascular complications in diabetes mellitus. Clin J Am Soc Nephrol (2010) 1.07
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis (2012) 1.07
Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res (2011) 1.06
Coincident idiopathic focal segmental glomerulosclerosis collapsing variant and diabetic nephropathy in an African American homozygous for MYH9 risk variants. Hum Pathol (2010) 1.05
Reappraisal of the impact of race on survival in patients on dialysis. Am J Kidney Dis (2010) 1.04
Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis. Am J Nephrol (2010) 1.04
Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report. Am J Kidney Dis (2010) 1.04
The relationship between albuminuria and hormone therapy in postmenopausal women. Am J Kidney Dis (2005) 1.04
End-stage renal failure in African Americans: insights in kidney disease susceptibility. Nephrol Dial Transplant (2002) 1.03
Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study. Diab Vasc Dis Res (2008) 1.03
Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes (2004) 1.02
Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study. Cardiovasc Diabetol (2013) 1.02
Ethnic differences in the relationship between pericardial adipose tissue and coronary artery calcified plaque: African-American-diabetes heart study. J Clin Endocrinol Metab (2010) 1.02
The impact of pedigree structure on heritability estimates for pulse pressure in three studies. Hum Hered (2005) 1.02
Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA. Hum Genet (2010) 1.01
APOL1 and progression of nondiabetic nephropathy. J Am Soc Nephrol (2013) 1.01
A comparison of type 2 diabetes risk allele load between African Americans and European Americans. Hum Genet (2014) 1.01
Genome-wide association of BMI in African Americans. Obesity (Silver Spring) (2011) 1.01
Novel findings and future directions on the genetics of hypertension. Curr Opin Nephrol Hypertens (2012) 1.00
Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans. Genomics (2010) 1.00
Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am Heart J (2006) 1.00
The relationship between C-reactive protein and subclinical cardiovascular disease in the Diabetes Heart Study (DHS). Am Heart J (2005) 0.99
MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS Genet (2013) 0.99
Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis (2008) 0.99
Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the Diabetes Heart Study. Diabetes Care (2014) 0.98
Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation. Clin J Am Soc Nephrol (2010) 0.98
Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol (2005) 0.97